Edwards Lifesciences (EW) Change in Inventory (2009 - 2026)

Edwards Lifesciences has reported Change in Inventory for 18 years, with the latest figure at $1.6 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Inventory rose 1500.0% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at -$49.2 million (down 126.35% YoY), and the FY2025 full-year result was -$50.7 million, down 119.8% from the prior year.
• Change in Inventory for Q1 2026 stood at $1.6 million, up from -$11.0 million in the prior quarter.
• The five-year high for Change in Inventory was $99.3 million in Q4 2023, with the low at -$41.6 million in Q2 2025.
• Average Change in Inventory over 5 years is $41.7 million, with a median of $51.2 million recorded in 2024.
• Year-over-year, Change in Inventory plunged 144.16% in 2025 and soared 1500.0% in 2026.
• Tracing EW's Change in Inventory over 5 years: stood at $62.3 million in 2022, then jumped by 59.39% to $99.3 million in 2023, then sank by 48.44% to $51.2 million in 2024, then slumped by 121.48% to -$11.0 million in 2025, then soared by 114.55% to $1.6 million in 2026.
• The last three Change in Inventory figures came in at $1.6 million (Q1 2026), -$11.0 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.

Peer Comparison